iTeos Therapeutics, Inc.
ITOS
$10.13
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -7.29% | -7.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 68.75% | -18.47% | |||
| Operating Income | -68.75% | 18.47% | |||
| Income Before Tax | -129.94% | 7.82% | |||
| Income Tax Expenses | 51.82% | -85.04% | |||
| Earnings from Continuing Operations | -127.46% | 20.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -127.46% | 20.82% | |||
| EBIT | -68.75% | 18.47% | |||
| EBITDA | -69.28% | 18.59% | |||
| EPS Basic | -125.76% | 20.92% | |||
| Normalized Basic EPS | -79.85% | 7.94% | |||
| EPS Diluted | -126.11% | 21.00% | |||
| Normalized Diluted EPS | -79.85% | 7.94% | |||
| Average Basic Shares Outstanding | 0.75% | 0.14% | |||
| Average Diluted Shares Outstanding | 0.75% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||